Navigation Links
Solazyme Announces New Senior Vice President of Business Development

Troy J. Campione, Ph.D., Joins Solazyme Executive Team

SOUTH SAN FRANCISCO, Calif., Oct. 3 /PRNewswire/ -- Solazyme, a bioscience company pioneering biofuels and health/wellness products from microalgae, has named Troy J. Campione, Ph.D., to the position of senior vice president of business development.

Campione will lead the development, negotiation, and finalization of partnership agreements and contracts with major companies. These deals will help fund research and development programs leveraging Solazyme's work on biofuels and industrial chemicals.

Campione has extensive experience monetizing technology across diverse industries and geographies. Most recently he was general manager and vice president of Symyx Technologies, Inc., a company providing high throughput research and informatics technologies globally to the chemical, energy, polymer, pharmaceutical, and electronics industries. At Symyx, he was accountable for collaborative research, strategic alliances, and materials licensing. During his tenure, Campione leveraged the company's technology position to negotiate more than $400 million of new research services, products, and licensing revenues with major chemical and energy companies including ExxonMobil, Dow Chemical, BP, Ineos, Innovene, and Celanese.

"Troy's breadth of experience in developing strategic alliances along with his talent for licensing technologies will enhance our ability to develop relationships with potential partners as we commercialize our algal-based technologies," said Jonathan Wolfson, president and chief operating officer of Solazyme. "We are extremely excited to have him join our management team."

Prior to Symyx, Campione spent 15 years at ExxonMobil in business, research and development, and technology management positions in Houston, Baytown, and Baton Rouge. He led the research and development activities for advanced catalyst and process technologies as worldwide basic chemicals technology manager, delivered continued success and growth of the vinyl intermediates area as its business manager, and prioritized, championed, and secured significant chemical plant expansions for the intermediates business of Exxon Chemical.

Campione earned his Ph.D. in chemical engineering from the University of Texas at Austin and also holds M.E. and B.S degrees in Chemical Engineering from Tulane University.

About Solazyme:

Founded in 2003 and headquartered in South San Francisco, California, Solazyme is a leading biotechnology company focused on the engineering and optimization of algae for production of biofuels and health and wellness materials. For more information, please visit our website:

For More Information Contact:

Jackie Kolek Ellen Snook

Peppercom Peppercom

212-931-6166 415-438-9821

SOURCE Solazyme
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Global Stem Cells Group ... of a new closed system for isolating adipose-derived stem cells. The announcement starts a ... of adipose tissue. SVF is a component of the lipoaspirate obtained from liposuction of ...
(Date:11/30/2015)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), a leader in ... Business Act on Climate Pledge, alongside more than 140 companies ... Obama Administration to demonstrate an ongoing commitment to climate action ... COP21 Paris climate negotiations. ... Canada . --> BioAmber uses biotechnology to ...
(Date:11/30/2015)... 30, 2015 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or the ... C.W. Wong to its Board of Directors to replace ... with a wealth of experience as co-founder of Resverlogix, with ... --> --> Dr. Wong remarked, ... of directors. Zenith,s long standing expertise in epigenetics and the ...
(Date:11/30/2015)... SAN DIEGO , Nov. 30, 2015 ... today that the company has acquired Cypher Genomics, Inc., ... and robust human genomic interpretation software solutions. The ... who will join HLI including Cypher CEO and Co-founder, ... head of HLI,s Pediatric Business.  Financial details of the ...
Breaking Biology Technology:
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces today ... its Board of Directors. --> ... recently retiring from the partnership at TPG Capital, one ... with over $140 Billion in revenue.  He founded and ... all the TPG companies, from 1997 to 2013.  In ...
(Date:11/12/2015)... 12, 2015  Arxspan has entered into an ... Harvard for use of its ArxLab cloud-based suite ... The partnership will support the institute,s efforts to ... research information internally and with external collaborators. The ... managing the Institute,s electronic laboratory notebook, compound and ...
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
Breaking Biology News(10 mins):